🇺🇸 FDA
Patent

US 6509344

Indenoisoquinolines as antineoplastic agents

expired A61PA61P35/00

Quick answer

US patent 6509344 (Indenoisoquinolines as antineoplastic agents) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jan 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
54
CPC classes
A61P, A61P35/00